The LiFT study has 3 goals:
Learn more about NASH and lower testosterone below.
- To explore the correlation between fat in the liver (specifically NASH) and lower testosterone
- To evaluate the ability of testosterone to lower liver fat
- To evaluate the ability of testosterone to improve liver health
What is NASH?
NASH is a stage of liver disease that causes inflammation and fat build-up in the liver. You may not notice symptoms with NASH, but it can lead to permanent liver scarring (cirrhosis). NASH can be more common in people with certain medical conditions like obesity, type 2 diabetes, or lower testosterone (hypogonadism).
What is lower testosterone?
Lower testosterone, or hypogonadism, happens when the body does not produce normal levels of the testosterone hormone. Men with lower testosterone are at high risk for NASH. The study drug not only provides testosterone, but it may also help with NASH and fat in the liver.